Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

AMP-activated protein kinase signaling is upregulated in papillary thyroid cancer.

Vidal AP, Andrade BM, Vaisman F, Cazarin J, Pinto LF, Breitenbach MM, Corbo R, Caroli-Bottino A, Soares F, Vaisman M, Carvalho DP.

Eur J Endocrinol. 2013 Sep 17;169(4):521-8. doi: 10.1530/EJE-13-0284. Print 2013 Oct.

2.

Trefoil factor 3 immunohistochemical characterization of follicular thyroid lesions from tissue microarray.

Patel MR, Bryson PC, Shores CG, Hart CF, Thorne LB, Deal AM, Zanation AM.

Arch Otolaryngol Head Neck Surg. 2009 Jun;135(6):590-6. doi: 10.1001/archoto.2009.54.

PMID:
19528408
3.

Histological evaluation of AMPK signalling in primary breast cancer.

Hadad SM, Baker L, Quinlan PR, Robertson KE, Bray SE, Thomson G, Kellock D, Jordan LB, Purdie CA, Hardie DG, Fleming S, Thompson AM.

BMC Cancer. 2009 Sep 1;9:307. doi: 10.1186/1471-2407-9-307.

4.

Association between phosphorylated AMP-activated protein kinase and acetyl-CoA carboxylase expression and outcome in patients with squamous cell carcinoma of the head and neck.

Su YW, Lin YH, Pai MH, Lo AC, Lee YC, Fang IC, Lin J, Hsieh RK, Chang YF, Chen CL.

PLoS One. 2014 Apr 25;9(4):e96183. doi: 10.1371/journal.pone.0096183. eCollection 2014.

5.

Expression of the sonic hedgehog pathway molecules in synchronous follicular adenoma and papillary carcinoma of the thyroid gland in predicting malignancy.

Nelson KK, Gattuso P, Xu X, Prinz RA.

Surgery. 2010 Oct;148(4):654-60; discussion 660. doi: 10.1016/j.surg.2010.07.030. Epub 2010 Aug 24.

PMID:
20797751
6.

SIN1, a critical component of the mTOR-Rictor complex, is overexpressed and associated with AKT activation in medullary and aggressive papillary thyroid carcinomas.

Moraitis D, Karanikou M, Liakou C, Dimas K, Tzimas G, Tseleni-Balafouta S, Patsouris E, Rassidakis GZ, Kouvaraki MA.

Surgery. 2014 Dec;156(6):1542-8; discussion 1548-9. doi: 10.1016/j.surg.2014.08.095. Epub 2014 Nov 11.

PMID:
25456951
7.

MUC1 mucin gene, transcripts, and protein in adenomas and papillary carcinomas of the thyroid.

Bièche I, Ruffet E, Zweibaum A, Vildé F, Lidereau R, Franc B.

Thyroid. 1997 Oct;7(5):725-31.

PMID:
9349575
8.

AMP-activated protein kinase upregulates glucose uptake in thyroid PCCL3 cells independent of thyrotropin.

Andrade BM, Cazarin J, Zancan P, Carvalho DP.

Thyroid. 2012 Oct;22(10):1063-8. doi: 10.1089/thy.2012.0041. Epub 2012 Sep 6.

PMID:
22953992
9.

ERK phosphorylation is not increased in papillary thyroid carcinomas with BRAF(V600E) mutation compared to that of corresponding normal thyroid tissues.

Kim SW, Kim HK, Lee JI, Jang HW, Choe JH, Kim JH, Kim JS, Hur KY, Kim JH, Chung JH.

Endocr Res. 2013;38(2):89-97. doi: 10.3109/07435800.2012.723292.

PMID:
23544999
10.

Tumor suppressor role of the CL2/DRO1/CCDC80 gene in thyroid carcinogenesis.

Ferraro A, Schepis F, Leone V, Federico A, Borbone E, Pallante P, Berlingieri MT, Chiappetta G, Monaco M, Palmieri D, Chiariotti L, Santoro M, Fusco A.

J Clin Endocrinol Metab. 2013 Jul;98(7):2834-43. doi: 10.1210/jc.2012-2926. Epub 2013 May 10.

PMID:
23666966
11.

NDRG1 protein overexpression in malignant thyroid neoplasms.

Gerhard R, Nonogaki S, Fregnani JH, Soares FA, Nagai MA.

Clinics (Sao Paulo). 2010 Jun;65(8):757-62.

12.

Raf-1 kinase inhibitory protein expression in thyroid carcinomas.

Kim HS, Kim GY, Lim SJ, Kim YW.

Endocr Pathol. 2010 Dec;21(4):253-7. doi: 10.1007/s12022-010-9131-x.

PMID:
20734161
13.

CD117 expression in normal, neoplastic, inflammatory, and reactive lesions of the thyroid.

Aydin O, Yildiz L, Kefeli M, Kandemir B.

Pathol Res Pract. 2008;204(6):359-65. doi: 10.1016/j.prp.2008.01.003. Epub 2008 Mar 11.

PMID:
18337018
14.

Impact of Metformin and compound C on NIS expression and iodine uptake in vitro and in vivo: a role for CRE in AMPK modulation of thyroid function.

Abdulrahman RM, Boon MR, Sips HC, Guigas B, Rensen PC, Smit JW, Hovens GC.

Thyroid. 2014 Jan;24(1):78-87. doi: 10.1089/thy.2013.0041. Epub 2013 Sep 25.

PMID:
23819433
15.

Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation.

Savin S, Cvejic D, Isic T, Paunovic I, Tatic S, Havelka M.

Hum Pathol. 2008 Nov;39(11):1656-63. doi: 10.1016/j.humpath.2008.04.006. Epub 2008 Jul 26.

PMID:
18657294
16.

Expression of sodium iodide symporter in benign and malignant human thyroid tissues.

Lin JD, Hsueh C, Chao TC, Weng HF.

Endocr Pathol. 2001 Spring;12(1):15-21.

PMID:
11478264
17.

The RET/PTC oncogene is frequently activated in oncocytic thyroid tumors (Hurthle cell adenomas and carcinomas), but not in oncocytic hyperplastic lesions.

Chiappetta G, Toti P, Cetta F, Giuliano A, Pentimalli F, Amendola I, Lazzi S, Monaco M, Mazzuchelli L, Tosi P, Santoro M, Fusco A.

J Clin Endocrinol Metab. 2002 Jan;87(1):364-9.

PMID:
11788677
18.

Expression of ras oncogene p21 antigen in normal and proliferative thyroid tissues.

Johnson TL, Lloyd RV, Thor A.

Am J Pathol. 1987 Apr;127(1):60-5.

19.

Negative/low expression of the Met/hepatocyte growth factor receptor identifies papillary thyroid carcinomas with high risk of distant metastases.

Belfiore A, Gangemi P, Costantino A, Russo G, Santonocito GM, Ippolito O, Di Renzo MF, Comoglio P, Fiumara A, Vigneri R.

J Clin Endocrinol Metab. 1997 Jul;82(7):2322-8.

PMID:
9215314
20.

AMP-activated protein kinase activation leads to lysome-mediated NA(+)/I(-)-symporter protein degradation in rat thyroid cells.

Cazarin JM, Andrade BM, Carvalho DP.

Horm Metab Res. 2014 May;46(5):313-7. doi: 10.1055/s-0034-1371803. Epub 2014 Apr 1.

PMID:
24691731

Supplemental Content

Support Center